Entry Detail



General Information

Database ID:exR0012096
RNA Name:RHOA
RNA Type:mRNA
Chromosome:chr3
Starnd:-
Coordinate:
Start Site(bp):49359145End Site(bp):49412998
External Links:ENSG00000067560



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC012254.2
chr18
47108188
47176345
-
AL603832.3
chr1
112702614
112711433
-
AKAP9
chr7
91940867
92110673
+
AC010422.3
chr19
12643831
12648397
-
AC008982.1
chr19
38817471
38840178
-
AC087289.3
chr17
75898645
75930129
-
AL928654.3
chr14
105487199
105492267
+
AC023055.1
chr12
55757275
55827546
-
ABCE1
chr4
145098288
145129524
+
ADIPOR1
chr1
202940826
202958572
-
ADAM10
chr15
58588809
58749791
-
ACAT2
chr6
159762045
159779112
+
AL022238.4
chr22
40346529
40410054
+
AC007192.1
chr19
18153158
18178117
+
AHCY
chr20
34280268
34311802
-
AC008763.3
chr19
7678501
7682854
+
ACTB
chr7
5527148
5563784
-
ADSL
chr22
40346500
40390463
+
ABHD14B
chr3
51968510
51983409
-
ACACA
chr17
37084992
37406836
-
ACIN1
chr14
23058564
23095614
-
ACTG1
chr17
81509971
81523847
-
AL590764.2
chrX
71103987
71111575
-
AC135050.2
chr16
31083439
31094956
-
ADNP2
chr18
80109262
80147523
+
AC245033.1
chr15
82536788
82573194
-
ACTL6A
chr3
179562886
179588407
+
AC027796.3
chr17
3585149
3636249
-
ADCY1
chr7
45574140
45723116
+
AK2
chr1
33007940
33080996
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-122-5p
chr18
58451088
58451109
+
hsa-miR-130b-3p
chr22
21653354
21653375
+
hsa-miR-454-3p
chr17
59137787
59137809
-
hsa-miR-1244
chr2
231713368
231713393
+
hsa-miR-4284
chr7
73711327
73711344
+
hsa-miR-4492
chr11
118910765
118910781
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005062.1
chr7
19918981
20140453
-
AC007952.4
chr17
19112000
19112636
-
AC023509.1
chr12
53441741
53467528
+
AC073050.1
chr2
167293171
167558333
+
AC093227.1
chr19
37728586
37730643
-
AC245033.4
chr15
82533175
82540008
-
AL022311.1
chr22
37876148
37895563
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.